Avantor, Inc. Other Current Liabilities
Avantor, Inc. (AVTR) had Other Current Liabilities of $401.50 million as of 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-04-29
- 2026-03-31: Other Liabilities, Current $401.50M.
- 2025-12-31: Other Liabilities, Current $396.40M.
- 2025-09-30: Other Liabilities, Current $391.40M.
- 2025-06-30: Other Liabilities, Current $388.60M.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-03-31 | $401.50M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $396.40M 10-Q · filed 2026-04-29 |
| 2025-09-30 | $391.40M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $388.60M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $346.90M 10-Q · filed 2025-04-25 |
| 2024-12-31 | $306.80M 10-K · filed 2026-02-11 |
| 2024-09-30 | $401.70M 10-Q · filed 2024-10-25 |
| 2024-06-30 | $352.80M 10-Q · filed 2024-07-26 |
| 2024-03-31 | $395.70M 10-Q · filed 2024-04-26 |
| 2023-12-31 | $411.20M 10-K · filed 2025-02-07 |
| 2023-09-30 | $337.10M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $375.90M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $414.60M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $364.10M 10-K · filed 2024-02-14 |
| 2022-09-30 | $343.80M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $359.30M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $409.50M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $401.00M 10-K · filed 2023-02-14 |
| 2021-09-30 | $380.50M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $390.90M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $340.20M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $313.60M 10-K · filed 2022-02-11 |
| 2020-09-30 | $302.40M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $267.90M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $252.40M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $232.30M 10-K · filed 2021-02-16 |
| 2019-09-30 | $227.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $225.40M 10-Q · filed 2019-08-06 |
| 2018-12-31 | $174.90M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |